Explantation of a sutureless scleral fixated Carlevale intraocular lens due to calcification: a clinical and laboratory report

BMC Ophthalmology

Case Report

Petros G. Koutsoukos¹  Panagiota D. Natsi¹  Efthymios Karmiris²  Panos S. Gartaganis²  Evangelos Manousakis²  Sotirios P. Gartaganis³ 

[1] Department of Chemical Engineering, Laboratory of Inorganic and Analytical Chemistry, University of Patras and FORTH/ICE-HT, Patras, Greece;Department of Ophthalmology, 251 Hellenic Air Force General Hospital, 16 Avras Str, 166 73, Athens, Greece;Department of Ophthalmology, Medical School, University of Patras, Patras, Greece;

关键词: Hydrophilic acrylic intraocular lens;    Calcification;    Opacification;   

DOI  :  10.1186/s12886-023-03102-0

 received in 2023-01-30, accepted in 2023-08-09,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundHydrophilic intraocular lens opacification is a rare complication due to calcification. With current new surgical techniques, including lamellar endothelial keratoplasty and vitrectomies, this irreversible complication is becoming more common. In this case study, we present clinical and laboratory features of a case of Carlevale hydrophilic acrylic IOL calcification.Case presentationObservational case report of a single incident case. An 83-year-old man was referred to our ophthalmic department complaining of right eye vision blurring for six months. Slit-lamp biomicroscopy revealed IOL opacification. Deposits of calcium phosphate were found both on the IOL’s surface and inside it, according to thorough investigation using optical, scanning electron microscopy (SEM), and energy-dispersive X-ray (EDX) spectrometry.ConclusionsTo the best of our knowledge, this is the first case to describe the laboratory evidence of Carlevale hydrophilic IOL calcification, suggesting possible explanation mechanisms based on underlying pathology and surgical technique. It reminds us that these findings suggest that physicians should be aware of possible hydrophilic IOL calcification.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 6

Fig. 4

Fig. 2

Fig. 1

Fig. 3